Journal article
In HF with mitral regurgitation, adding transcatheter mitral valve repair to medical therapy improved renal outcomes at 2 y.
Abstract
SOURCE CITATION: Beohar N, Ailawadi G, Kotinkaduwa LN, et al. Impact of baseline renal dysfunction on cardiac outcomes and end-stage renal disease in heart failure patients with mitral regurgitation: the COAPT trial. Eur Heart J. 2022;43:1639-48. 35134897.
Authors
Damman K; Van Spall HGC
Journal
Annals of Internal Medicine, Vol. 175, No. 6,
Publisher
American College of Physicians
Publication Date
June 2022
DOI
10.7326/j22-0037
ISSN
1056-8751